Most Chi­nese firms could keep their US list­ings un­der draft frame­work — re­port

4 years ago
China
Pharma

In­spired by Break­ing Bad to make ricin, ex-biotech ex­ec sen­tenced for ly­ing to FBI

4 years ago
People

Sil­ver­back falls on hard times, ax­ing lead I/O can­di­dates and lay­ing off more than a fourth of staff

4 years ago
R&D

Changes in high-rank­ing ex­ecs poised to deep­en at Karyopharm; Till­man Gern­gross-chaired biotech pro­motes new med­ical ...

4 years ago
Peer Review

House pass­es $35 month­ly in­sulin caps, but Sen­ate re­mains a ques­tion mark

4 years ago
Pharma

FDA chief Rob Califf: The busi­ness of health is boom­ing but peo­ple's out­comes aren't im­prov­ing

4 years ago
FDA+

Rick Gon­za­lez stays in the win­ners cir­cle at Ab­b­Vie, grab­bing $24M comp pack­age

4 years ago
Pharma

Bio­haven’s top sci­en­tist stars in new ‘Idea­haven’ mi­graine cam­paign, adding to its mar­ket­ing bag of tricks

4 years ago
Pharma
Marketing

DoJ ‘Chi­na Ini­tia­tive’ probe in­to stem cell pi­o­neer Haifan Lin dis­con­tin­ued, lawyer says

4 years ago
People

Clo­vis On­col­o­gy her­alds a PARP vic­to­ry in front­line ovar­i­an can­cer — does any­one re­al­ly care much?

4 years ago
Bioregnum
Pharma

Flori­da be­comes next state to seal big opi­oid set­tle­ment deal, bag­ging $878M from Te­va, Al­ler­gan and oth­ers

4 years ago
Pharma

Taysha joins lay­off wave as Dal­las biotech paus­es most of its R&D work

4 years ago
People
R&D

Pear Ther­a­peu­tics sets the stage for a fruit­ful 2022, fore­cast­ing a five-fold boost in rev­enue

4 years ago
Pharma

Q&A: Lon­za­'s Chris­t­ian Dowdeswell talks HPA­PIs and the Oas­mia deal

4 years ago
Manufacturing

Bay­er to dump $2.26B in­to man­u­fac­tur­ing re­align­ment as it says good­bye to some sites

4 years ago
R&D
Manufacturing

AGC to use re­cent­ly-ex­pand­ed Ger­many site for peanut al­ler­gy drug tri­als

4 years ago
Manufacturing

In­dia of­fers in­cen­tives to do­mes­tic drug­mak­ers for APIs; Af­ter PhI­II tri­als, Tai­ho li­cens­es Arokaris in Japan

4 years ago
Manufacturing

A ran­somware at­tack on a Pfiz­er ven­dor trig­gered over­pay­ments to hourly staffers — and now the phar­ma gi­ant wants ...

4 years ago
R&D

On a mis­sion to re­shape Sanofi, Paul Hud­son takes a slight pay cut

4 years ago
People
Pharma

Can­cer drug de­vel­op­ers will learn from the blaz­ing speed of the Covid-19 vac­cine race, FDA lead­ers say

4 years ago
FDA+
Coronavirus

Roger Perl­mut­ter re­cruits an­oth­er Mer­ck vet to his new start­up: for­mer CEO Ken Fra­zier

4 years ago
People

Bel­gian VC be­hind Ab­b­Vie-owned Syn­de­si clos­es sec­ond in­vest­ment fund, se­cur­ing nine-fig­ure raise

4 years ago
Financing

Mukher­jee and Vale's Myeloid teams up with David Li­u's Prime Med­i­cine in race against Tessera

4 years ago
Startups
Deals

Up­dat­ed: SEC chair de­nies a deal to pre­vent Chi­nese com­pa­ny delist­ing is close — re­ports

4 years ago
China
Pharma
First page Previous page 547548549550551552553 Next page Last page
A service from the Financial Times